Boehringer Ingelheim

Human kidney anatomy
Biotech

Boehringer channels midstage momentum into pivotal kidney trial

Boehringer shared more phase 2 data on its kidney disease candidate, shedding light on the decision to start a pivotal trial of the prospect.
Nick Paul Taylor Jan 28, 2026 5:39am
IBD UC CD

Boehringer pens €1.05B deal for Simcere's IBD bispecific

Jan 27, 2026 7:30am
A ballpoint pen rests on top of a stack of documents ready for signing

Boehringer continues kidney dealmaking with $120M Variant pact

Jan 6, 2026 10:45am
pay deal hand over cash licensing transaction money

Boehringer spells out a $448M future for Rectify's ABC program

Dec 22, 2025 9:45am
holiday present with return label

2 pharmas turn Scrooge, returning biotechs' unwanted gifts

Dec 19, 2025 10:44am
pivot change turnaround direction walk away

Boehringer cuts ties to Nxera's phase 2-ready schizophrenia drug

Dec 19, 2025 6:35am